首页> 外文期刊>Clinical and experimental allergy : >Probiotics and primary prevention of atopic disease: Are we closer to a firm evidence base for clinical use?
【24h】

Probiotics and primary prevention of atopic disease: Are we closer to a firm evidence base for clinical use?

机译:益生菌和特应性疾病的一级预防:我们是否接近临床使用的可靠依据?

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To undertake a multi-country study to investigate the risk of acute hyperglycaemia with antipsychotic use. Methods: Using a distributed network model with a common minimal data set, we performed a prescription sequence symmetry analysis (PSSA) to investigate the risk of acute hyperglycaemia associated with antipsychotic initiation. Incident insulin prescriptions were used as a proxy indicator of acute hyperglycaemia. Participating countries and population datasets included Australia (300,000 persons), Japan I (300,000 persons), Japan II (200,000 persons), Korea (53 million persons) Taiwan (1 million persons), Sweden (9 million persons), USA-Public (87 million persons) and USA-Private (47 million persons). Results: Olanzapine showed a trend towards increased risk in most databases, with a significant association observed in the USA-Public database (Adjusted sequence ratio (ASR)=1.14; 95% Confidence Interval (CI) 1.10-1.17) and Sweden (ASR=1.53; 95% CI 1.13-2.06). Null or negative associations were observed for haloperidol, quetiapine and risperidone. Conclusion: Acute hyperglycaemia appears to be associated with olanzapine use, however, this effect was only observed in two large databases. Despite different patterns of utilization of both antipsychotics and insulin, PSSA analysis results for individual antipsychotic medicines were qualitatively similar across most countries. PSSA, used in conjunction with existing methods, may provide a simple and timely method further supporting multi-national drug safety monitoring.
机译:目的:进行一项多国研究,以研究使用抗精神病药引起的急性高血糖的风险。方法:使用具有最小公共数据集的分布式网络模型,我们进行了处方序列对称性分析(PSSA),以调查与抗精神病药物引发相关的急性高血糖的风险。胰岛素事件处方被用作急性高血糖的替代指标。参与国家和人口数据集包括澳大利亚(300,000人),日本I(300,000人),日本II(200,000人),韩国(5,300万人),台湾(100万人),瑞典(900万人),美国-公众( 8700万人)和美国私人(4700万人)。结果:奥氮平在大多数数据库中均显示出风险增加的趋势,在美国-公共数据库(调整后的序列比(ASR)= 1.14; 95%置信区间(CI)1.10-1.17)和瑞典(ASR = 1.53; 95%CI 1.13-2.06)。氟哌啶醇,喹硫平和利培酮的相关性为零或阴性。结论:急性高血糖症似乎与奥氮平的使用有关,但是,仅在两个大型数据库中观察到了这种作用。尽管使用抗精神病药和胰岛素的方式不同,但在大多数国家中,针对每种抗精神病药的PSSA分析结果在质量上都相似。 PSSA与现有方法结合使用,可以提供一种简单及时的方法,进一步支持跨国药品安全性监控。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号